Melanin Concentrating Hormone Receptor 1 – Disease Assessment and Therapeutics Analysis Forecasts to 2024

PUNE, INDIA, March 20, 2018 /EINPresswire.com/ — WiseGuyReports.com with their unique quality of simplifying the market research study, presents a deep diving study report “Melanin-Concentrating Hormone Receptor 1 (G Protein-Coupled Receptor 24 or MCH 1R or Somatostatin Receptor Like Protein or GPR24 or SLC1 or MCHR1) – Pipeline Review, H1 2018”

Melanin Concentrating  

Overview

Melanin Concentrating Hormone Receptor 1 (G Protein Coupled Receptor 24 or MCH 1R or Somatostatin Receptor Like Protein or GPR24 or SLC1 or MCHR1) – Melanin-concentrating hormone receptor 1 also known as MCH1 is one of the human melanin-concentrating hormone receptors. MCH1 is a target for the orexigenic peptide leptin, which supports a role for MCH receptors in the control of food intake and energy expenditure.

The latest report Melanin Concentrating Hormone Receptor 1 – Pipeline Review, H1 2018, outlays comprehensive information on the Melanin Concentrating, targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Click here for sample report @ https://www.wiseguyreports.com/sample-request/3066583-melanin-concentrating-hormone-receptor-1-g-protein-coupled

Top Companies mentioned

AstraZeneca Plc

Boehringer Ingelheim GmbH

ConSynance Therapeutics Inc

Takeda Pharmaceutical Co Ltd

Melanin Concentrating Industry Major Outlook

Pharmaceutical and Healthcare latest pipeline guide Melanin Concentrating    – Pipeline Review, H1 2018, provides comprehensive information on the therapeutics under development for Melanin Concentrating   , complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

MCH1 helps in regulation of stress, anxiety and depression. The molecules developed by companies in Phase I and Preclinical stages are 1 and 4 respectively. Report covers products from therapy areas Metabolic Disorders and Gastrointestinal which include indications Obesity and Non-Alcoholic Steatohepatitis (NASH).

Melanin Concentrating pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Melanin Concentrating – Competitive Analysis

Key players are making innovative developments in Melanin Concentrating industry.  The same will help in improving the market performance. Heavy investments are made by major players in the R&D sector

Scope

The pipeline guide provides a snapshot of the global therapeutic landscape of Melanin Concentrating.

The pipeline guide reviews pipeline therapeutics for Melanin Concentrating by companies and universities/research institutes based on information derived from company and industry-specific sources.

The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 

The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

The pipeline guide reviews key companies involved in Melanin Concentrating therapeutics and enlists all their major and minor projects.

The pipeline guide evaluates Melanin Concentrating therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

The pipeline guide encapsulates all the dormant and discontinued pipeline projects. 

The pipeline guide reviews latest news related to pipeline therapeutics for Melanin Concentrating.

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/3066583-melanin-concentrating-hormone-receptor-1-g-protein-coupled

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

www.wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire